7 December 2016
The Wellcome Trust has today announced five-year funding for 14 major research centres, including a centre for neuroimaging in Oxford
14 April 2016
The world’s largest health imaging study, funded by the Medical Research Council, Wellcome Trust, and the British Heart Foundation is launched today. It will create the biggest collection of scans of internal organs, and transform the way scientists study a wide range of diseases.
26 October 2015
Harry Orlans will work with Robert MacLaren to develop a treatment for retinitis pigmentosa.
2 October 2015
Researchers in our Department will lead a new collaborative initiative for Spinal Muscular Atrophy (SMA) research in the UK over the next three years. The programme is funded by the SMA Trust.
3 September 2015
Researchers and clinicians from Oxford and Portsmouth have been awarded £1.8m by the Health Innovation Challenge Fund to develop a new electronic system to recognise deteriorating patients in hospitals.
10 March 2015
Oxford receives major funding to work on Parkinson’s, a neurological condition which can leave people struggling to walk, speak and sleep.
7 January 2015
Innovate UK has awarded an Oxford-based consortium £850k to validate epigenetic signatures in patients with the motor neurone disease Amyotrophic Lateral Sclerosis (ALS).
20 November 2014
Professor Duncan Young has been awarded £280,000 by the National Institute for Health Research (NIHR) to look at the problem of noise levels and sleep in the intensive care unit.
9 October 2014
Can physical fitness improve academic achievement? Would teenagers do better in their exams if they could sleep in and start school later? These questions will be part of a multi-million pound research project, funded by the Wellcome Trust and the Education Endowment Foundation (EEF), to investigate a variety of ways neuroscience might improve teaching and learning in the UK.
3 December 2012
Oxford University has recently led a successful bid to establish a €52M international consortium to develop induced pluripotent stem (iPS) cell lines for drug discovery and safety assessment.